.

Thursday, November 7, 2013

Novartis Review

Novartis Novartis AG Latest results: Country: Sector: Bloomberg Ticker: Q4 2010 Switzerland medicine company NVS.OL Industry view: caller-up view: Company military rating: Risk Quality Valuation profane the complete reputation Buy the complete Report deplorable MED. HIGH - - - Indigo Equity look Limited entropy@indigo-equity-research.com www.indigo-equity-research.com 15 Feb 2011 Investment Profile Note that this is a trivial version of a more than complete (6 page) base on Novartis. Executive Summary Novartis has the profile of a mettlesome quality, base hit and reliable company. This is a reflection of Novartis having grown revenues, EPS and dividends relatively consistently over the last ten years, with stable avail margins. gearing is low and cash flow is strong. As a value contain the high dividend yield is crucial to its valuation. Overall, Novartis has performed well compared to its peers and given up the negative pharma industry trends. Crit ically, it has mostly avoided major juridic proceeding & PR disasters of that other pharma companies have had. It is operationally diversify with pharma, vaccines & diagnostics, generics, and consumer health divisions.
Ordercustompaper.com is a professional essay writing service at which you can buy essays on any topics and disciplines! All custom essays are written by professional writers!
Buy the complete report for more enlarge package bell - Last 10 age 70 60 50 USD 40 30 20 10 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 0 NOVARTIS S&P 500 (Rebased) crownwork Structure parting Price Number of Shares (bn) Market capitalization pelf (Debt) / Cash nonage Interests & Prefs Enterprise Value (EV) mesh Debt / Market Cap. Financial Results y/e 31 fall Sales EBIT Net Income Share Capital Total addition! s FCF Per Share Data EPS DPS Cash EPS BV strength analysis EBIT Margin Net Profit Margin Asset Turnover Net gear wheel** ($) ($) ($) ($) 2010 ($ Bn) 50.6 11.5 9.8 63.2 123.3 11.8 2010 4.28 2.20 5.18 27.64 2010 22.8 % 19.3 % 41.1 % 195.1 % Per Share ($) 55.9 Total ($ Bn) 2.3 127.9 -14.9 142.8 12% 2012e ($ Bn) 60.2 9.8 7.6 69.0 129.9 8.3 2012e 3.32 2.84 3.61 30.20 2012e 16.3 % 12.6 % 46.3 % 188.1 % 11.0 % 2012e...If you want to get a full essay, order it on our website: OrderCustomPaper.com

If you want to get a full essay, visit our page: write my paper

No comments:

Post a Comment